NOVEL EGFR/PI3K DUAL-TARGETING NANOPARTICLES INDUCE IMMUNOGENIC CELL DEATH IN BLADDER CANCER

被引：0
作者：
Zhu, Zheng [1 ]
Xue, Xiangdong [2 ]
Zhou, Gang [3 ]
Song, Zewen [4 ]
Li, Guoyin [5 ]
机构：
[1] Harvard Med Sch, West Roxbury, MA USA
[2] Shanghai Jiao Tong Univ, Shanghai, Peoples R China
[3] Fourth Millitary Med Univ, Xian, Peoples R China
[4] Cent South Univ, Changsha, Peoples R China
[5] Zhoukou Normal Univ, Zhoukou, Henan, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1358
引用
收藏
页码：A1409 / A1409
页数：1
相关论文
共 50 条
[31]   Analysis of PI3K pathway genes in bladder cancer [J].
Seven, Didem ;
Tigli, Hatice ;
Buyru, Nur .
CANCER RESEARCH, 2012, 72
[32]   A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy [J].
Fan, Fushun ;
Liu, Pei ;
Bao, Rudi ;
Chen, Jian ;
Zhou, Minhua ;
Mo, Zhenxian ;
Ma, Yaru ;
Liu, Haiqi ;
Zhou, Yiping ;
Cai, Xiong ;
Qian, Changgeng ;
Liu, Xinjian .
CANCER RESEARCH, 2021, 81 (24) :6233-6245
[33]   Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition [J].
Tang, K. D. ;
Ling, Ming-Tat .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) :3048-3056
[34]   Inhibiting pancreatic cancer growth by dual targeting of ERK and PI3K signaling. [J].
Nair, Gauthami G. ;
Reindl, Katie ;
Quadir, Mohiuddin .
CANCER RESEARCH, 2022, 82 (22) :104-104
[35]   Brain penetrant HDAC and PI3K/mTOR inhibitors synergize to induce DIPG cell death [J].
Barnett, Katherine ;
Kwon, Hyuk Jean ;
Novak, Orlandi ;
Eberhart, Charles ;
Raabe, Eric .
CANCER RESEARCH, 2022, 82 (12)
[36]   Targeting PI3K in cancer: any good news? [J].
Martini, Miriam ;
Ciraolo, Elise ;
Gulluni, Federico ;
Hirsch, Emilio .
FRONTIERS IN ONCOLOGY, 2013, 3
[37]   Targeting PI3K signaling in cancer: Challenges and advances [J].
De Santis, Maria Chiara ;
Gulluni, Federico ;
Campa, Carlo Cosimo ;
Martini, Miriam ;
Hirsch, Emilio .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (02) :361-366
[38]   Targeting PI3K Signaling in Combination Cancer Therapy [J].
Pons-Tostivint, Elvire ;
Thibault, Benoit ;
Guillermet-Guibert, Julie .
TRENDS IN CANCER, 2017, 3 (06) :454-469
[39]   Targeting PI3K/Akt/mTOR signaling in cancer [J].
Porta, Camillo ;
Paglino, Chiara ;
Mosca, Alessandra .
FRONTIERS IN ONCOLOGY, 2014, 4
[40]   A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation [J].
Luo, Kaipei ;
Yang, Lu ;
Yan, Chunmei ;
Zhao, Yuxin ;
Li, Qiuxia ;
Liu, Xing ;
Xie, Long ;
Sun, Qiang ;
Li, Xiaofang .
SMALL, 2023, 19 (40)
12345